139 related articles for article (PubMed ID: 25622909)
1. Phosphatidylinositol 3-kinase, class 2 beta (PI3KC2β) isoform contributes to neuroblastoma tumorigenesis.
Russo A; Okur MN; Bosland M; O'Bryan JP
Cancer Lett; 2015 Apr; 359(2):262-8. PubMed ID: 25622909
[TBL] [Abstract][Full Text] [Related]
2. Intersectin 1 is required for neuroblastoma tumorigenesis.
Russo A; O'Bryan JP
Oncogene; 2012 Nov; 31(46):4828-34. PubMed ID: 22266851
[TBL] [Abstract][Full Text] [Related]
3. The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma.
Amoroso F; Capece M; Rotondo A; Cangelosi D; Ferracin M; Franceschini A; Raffaghello L; Pistoia V; Varesio L; Adinolfi E
Oncogene; 2015 Oct; 34(41):5240-51. PubMed ID: 25619831
[TBL] [Abstract][Full Text] [Related]
4. A new dimension to Ras function: a novel role for nucleotide-free Ras in Class II phosphatidylinositol 3-kinase beta (PI3KC2β) regulation.
Wong KA; Russo A; Wang X; Chen YJ; Lavie A; O'Bryan JP
PLoS One; 2012; 7(9):e45360. PubMed ID: 23028960
[TBL] [Abstract][Full Text] [Related]
5. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
6. The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis.
Snapkov I; Öqvist CO; Figenschau Y; Kogner P; Johnsen JI; Sveinbjørnsson B
BMC Cancer; 2016 Jul; 16():490. PubMed ID: 27432059
[TBL] [Abstract][Full Text] [Related]
7. Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours.
Boller D; Doepfner KT; Laurentiis A; Guerreiro AS; Marinov M; Shalaby T; Depledge P; Robson A; Saghir N; Hayakawa M; Kaizawa H; Koizumi T; Ohishi T; Fattet S; Delattre O; Schweri-Olac A; Höland K; Grotzer MA; Frei K; Spertini O; Waterfield MD; Arcaro A
Anticancer Res; 2022 Jun; 42(6):3217-3230. PubMed ID: 35641277
[TBL] [Abstract][Full Text] [Related]
8. Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours.
Boller D; Doepfner KT; De Laurentiis A; Guerreiro AS; Marinov M; Shalaby T; Depledge P; Robson A; Saghir N; Hayakawa M; Kaizawa H; Koizumi T; Ohishi T; Fattet S; Delattre O; Schweri-Olac A; Höland K; Grotzer MA; Frei K; Spertini O; Waterfield MD; Arcaro A
Anticancer Res; 2012 Aug; 32(8):3015-27. PubMed ID: 22843869
[TBL] [Abstract][Full Text] [Related]
9. Silencing Intersectin 1 Slows Orthotopic Neuroblastoma Growth in Mice.
Harris J; Herrero-Garcia E; Russo A; Kajdacsy-Balla A; O'Bryan JP; Chiu B
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e413-e418. PubMed ID: 28787396
[TBL] [Abstract][Full Text] [Related]
10. ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastoma.
Li M; Sun C; Bu X; Que Y; Zhang L; Zhang Y; Zhang L; Lu S; Huang J; Zhu J; Wang J; Sun F; Zhang Y
Cell Death Dis; 2021 Jun; 12(6):620. PubMed ID: 34131100
[TBL] [Abstract][Full Text] [Related]
11. Src kinase family inhibitor PP2 induces aggregation and detachment of neuroblastoma cells and inhibits cell growth in a PI3 kinase/Akt pathway-independent manner.
Hishiki T; Saito T; Sato Y; Mitsunaga T; Terui E; Matsuura G; Saito E; Shibata R; Mise N; Yokoyama Y; Yoshida H
Pediatr Surg Int; 2011 Feb; 27(2):225-30. PubMed ID: 21046121
[TBL] [Abstract][Full Text] [Related]
12. Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma.
Qiao J; Kang J; Ishola TA; Rychahou PG; Evers BM; Chung DH
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12891-6. PubMed ID: 18753628
[TBL] [Abstract][Full Text] [Related]
13. Regulation of neuron survival through an intersectin-phosphoinositide 3'-kinase C2beta-AKT pathway.
Das M; Scappini E; Martin NP; Wong KA; Dunn S; Chen YJ; Miller SL; Domin J; O'Bryan JP
Mol Cell Biol; 2007 Nov; 27(22):7906-17. PubMed ID: 17875942
[TBL] [Abstract][Full Text] [Related]
14. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
15. Activation of Akt predicts poor outcome in neuroblastoma.
Opel D; Poremba C; Simon T; Debatin KM; Fulda S
Cancer Res; 2007 Jan; 67(2):735-45. PubMed ID: 17234785
[TBL] [Abstract][Full Text] [Related]
16. Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma.
Clark RA; Qiao J; Jacobson JC; Chung DH
Oncotarget; 2022; 13():32-45. PubMed ID: 35018218
[TBL] [Abstract][Full Text] [Related]
17. Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.
Boller D; Schramm A; Doepfner KT; Shalaby T; von Bueren AO; Eggert A; Grotzer MA; Arcaro A
Clin Cancer Res; 2008 Feb; 14(4):1172-81. PubMed ID: 18281552
[TBL] [Abstract][Full Text] [Related]
18. Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma.
Opel D; Naumann I; Schneider M; Bertele D; Debatin KM; Fulda S
Clin Cancer Res; 2011 May; 17(10):3233-47. PubMed ID: 21355080
[TBL] [Abstract][Full Text] [Related]
19. miR-362-5p inhibits proliferation and migration of neuroblastoma cells by targeting phosphatidylinositol 3-kinase-C2β.
Wu K; Yang L; Chen J; Zhao H; Wang J; Xu S; Huang Z
FEBS Lett; 2015 Jul; 589(15):1911-9. PubMed ID: 26073258
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity of p44/p42-MAPK- and PI3K/Akt-targeted neuroblastoma subtypes to arsenic trioxide.
Yousefi M; Ghaffari SH; Zekri A; Ghanizadeh-Vesali S; Hosseini E; Rostami M; Hassani S; Alimoghaddam K; Ghavamzadeh A
Neurochem Int; 2013 Dec; 63(8):809-17. PubMed ID: 24161621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
